Dibenzo(b,f)(1,4)oxazapine compounds

Details for Australian Patent Application No. 2008225014 (hide)

Owner ARYx Therapeutics, Inc.

Inventors Rubens, Courtney; Palme, Monica; Becker, Cyrus; Druzgala, Pascal; Adams, Jason

Agent Freehills

Pub. Number AU-A-2008225014

PCT Pub. Number WO2008/112900

Priority 60/895,046 15.03.07 US

Filing date 13 March 2008

Wipo publication date 18 September 2008

International Classifications

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/112900 Priority application(s): WO2008/112900

10 May 2012 Assignment before Grant

  ARYx Therapeutics, Inc. The application has been assigned to Andaman Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008225023-Sports matchmaker systems

2008224996-Production of biodiesel fuels which are low in glycerin and sulfur